CSIMarket



Adc Therapeutics Sa  (ADCT)
Other Ticker:  
 
 

ADCT's Operating Income Growth by Quarter and Year

Adc Therapeutics Sa's Operating Income results by quarter and year




ADCT Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December -261.72 -219.26 8.20 -422.70
III Quarter September - - -4.10 -25.20
II Quarter June - - -11.40 -17.40
I Quarter March - - 19.70 26.40
FY   -261.72 -219.26 12.40 -438.90



ADCT Operating Income forth quarter 2021 Y/Y Growth Comment
Adc Therapeutics Sa in the forth quarter 2021 recorded Operating Loss of $ -261.72 millions.

According to the results reported in the forth quarter 2021, Adc Therapeutics Sa achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Adc Therapeutics Sa' s Operating Income no change of % ranks overall at the positon no. in the forth quarter 2021.

Explain Operating Income growth


ADCT Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - -25.38 % 88.57 %
FY   - - - -

Financial Statements
Adc Therapeutics Sa's forth quarter 2021 Operating Income $ -261.72 millions ADCT's Income Statement
Adc Therapeutics Sa's forth quarter 2020 Operating Income $ -219.26 millions Quarterly ADCT's Income Statement
New: More ADCT's historic Operating Income Growth >>


ADCT Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -23.03 %
FY (Year on Year)   - - - -




Operating Income forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income forth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Adc Therapeutics Sa's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADCT's IV. Quarter Q/Q Operating Income Comment


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ADCT's IV. Quarter Q/Q Operating Income Comment


Adc Therapeutics Sa's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(March 30, 2010)
12 Months Ending
(Dec 31, 2009)
12 Months Ending
(Sep. 30, 2009)
Cumulative Operating Income 12 Months Ending $ -261.72 $ -219.26 $ 12.40 $ -418.50 $ -439.60
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Adc Therapeutics Sa' has realized cumulative trailing twelve months Operating Loss of $ -262 millions in the Dec 31 2021 period.
The situation is getting worse as the cumulative Operating Loss is getting bigger from $ -219.26 millions for the period from Dec 31 2020 to Sep. 30, 2009 and $ 0 millions from the TTM period ending Sep. 30, 2009.

Adc Therapeutics Sa achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Adc Therapeutics Sa' has realized cumulative trailing twelve months Operating Loss of $ -262 millions in the Dec 31 2021 period.
The results are worsening as the cumulative Operating Loss is becoming larger from $ -219.26 millions in TTM ending quarter Dec 31 2020 and $ 0 millions for the twelve months ending in the quarter a year ago.

Adc Therapeutics Sa achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ADCT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ADCT's Competitors
Operating Income Growth for Adc Therapeutics Sa's Suppliers
Operating Income Growth for ADCT's Customers

You may also want to know
ADCT's Annual Growth Rates ADCT's Profitability Ratios ADCT's Asset Turnover Ratio ADCT's Dividend Growth
ADCT's Roe ADCT's Valuation Ratios ADCT's Financial Strength Ratios ADCT's Dividend Payout Ratio
ADCT's Roa ADCT's Inventory Turnover Ratio ADCT's Growth Rates ADCT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2021
Fourth Wave Energy Inc 33.24%$ 33.239 millions
Legend Biotech Corporation30.96%$ 30.959 millions
Redhill Biopharma Ltd 27.40%$ 27.402 millions
National Research Corporation26.37%$ 26.367 millions
Check cap Ltd 24.33%$ 24.325 millions
Innoviva Inc 23.28%$ 23.282 millions
Vascular Biogenics Ltd 22.52%$ 22.518 millions
Bio techne Corp22.26%$ 22.263 millions
Corcept Therapeutics Inc20.17%$ 20.170 millions
Utah Medical Products Inc19.81%$ 19.808 millions
Surgery Partners Inc 19.21%$ 19.211 millions
Syneos Health Inc 18.81%$ 18.808 millions
Vertex Pharmaceuticals Inc17.69%$ 17.690 millions
Ensign Group Inc17.46%$ 17.464 millions
Zoetis Inc 16.08%$ 16.078 millions
Novartis Ag15.14%$ 15.140 millions
Sonida Senior Living Inc 13.63%$ 13.633 millions
Ligand Pharmaceuticals Incorporated13.60%$ 13.604 millions
Tenax Therapeutics Inc 13.36%$ 13.359 millions
Glucotrack Inc.12.53%$ 12.531 millions
Prestige Consumer Healthcare Inc 12.46%$ 12.460 millions
Xoma Corporation12.36%$ 12.359 millions
Resmed Inc 12.18%$ 12.175 millions
Phibro Animal Health Corp12.09%$ 12.086 millions
Henry Schein Inc 10.68%$ 10.685 millions
Integra Lifesciences Holdings Corp10.60%$ 10.595 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TOAC's Profile

Stock Price

TOAC's Financials

Business Description

Fundamentals

Charts & Quotes

TOAC's News

Suppliers

TOAC's Competitors

Customers & Markets

Economic Indicators

TOAC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071